©The Author(s) 2022.
World J Clin Oncol. May 24, 2022; 13(5): 366-375
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.366
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.366
Table 1 Comparison of demographic and clinical parameters of patients who underwent laparoscopic pancreatoduodenectomy with binding pancreaticogastrostomy and modified Blumgart pancreaticojejunostomy
| Variable | Binding PG group, n = 25 | Modified Blumgart PJ group, n = 25 | P value |
| Age in yr, median (range) | 53.7 (37-75) | 58.2 (31-79) | 0.12 |
| Sex, Male:Female | 14:11 | 15:10 | > 0.99 |
| BMI in kg/m2, median (range) | 23.8 (17.6-41.6) | 24.6 (18.2-40.0) | 0.69 |
| Jaundice, n (%) | 22 (88) | 21 (84) | > 0.99 |
| Cholangitis, n (%) | 8 (32) | 5 (20) | 0.52 |
| Peak total bilirubin levels in mg/dL, median (range) | 12.8 (1.2-28.3) | 10.6 (1.1-31.2) | 0.59 |
| Preoperative biliary drainage, n (%) | 14 (56) | 12 (48) | 0.78 |
| CA 19-9 (U/mL), median (range) | 55 (1-5682) | 84 (2-3318) | 0.12 |
| Diagnosis, n (%) | |||
| Cholangiocarcinoma | 9 (36) | 7 (28) | 0.76 |
| Pancreatic adenocarcinoma | 3 (12) | 2 (8) | > 0.99 |
| Ampullary adenocarcinoma | 7 (28) | 9 (36) | 0.76 |
| Duodenal adenocarcinoma | 3 (12) | 4 (16) | > 0.99 |
| Intraductal papillary mucinous | 2 (8) | 1 (4) | > 0.99 |
| Neoplasm pancreas | |||
| Neuroendocrine tumor | 1 (4) | 2 (8) | > 0.99 |
- Citation: Choudhury SR, Kalayarasan R, Gnanasekaran S, Pottakkat B. Modified binding pancreaticogastrostomy vs modified Blumgart pancreaticojejunostomy after laparoscopic pancreaticoduodenectomy for pancreatic or periampullary tumors. World J Clin Oncol 2022; 13(5): 366-375
- URL: https://www.wjgnet.com/2218-4333/full/v13/i5/366.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i5.366